(Q48029836)

English

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

author name string

R Lagos

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

M T Valenzuela

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

O S Levine

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

G A Losonsky

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

A Erazo

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

S S Wasserman

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

M M Levine

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

351

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

9114

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

1472-1476

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lag between discovery and production of new vaccines for the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907456-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)07456-4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

release_7yhxtagrjfgcvfedukrtwoxaii

1 reference

https://api.fatcat.wiki/v0/release/7yhxtagrjfgcvfedukrtwoxaii

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9605803

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48029836&oldid=1844619832"